Anixa Biosciences (ANIX) Non Operating Interest Expenses (2013 - 2020)
Anixa Biosciences' Non Operating Interest Expenses was $7,266 in fiscal Q3 2020 (quarter ended Jul 31, 2020), down 60.4% from $18,364 a year earlier.
Powered by 
Analysis
Anixa Biosciences (ANIX) Non Operating Interest Expenses (2013 - 2020) Analysis & Trends
On a trailing twelve-month basis, Anixa Biosciences' Non Operating Interest Expenses was $155,059 through Jul 31, 2020, down 52.1% year-over-year; for FY2017 (ended Oct 31, 2017), it was $500,455, down 3.7% from FY2016.
- Non Operating Interest Expenses shows a five-year compound annual growth rate of 130.7% (FY2012 to FY2017).
- In earlier fiscal years, Non Operating Interest Expenses was $519,946 in FY2016 (+15.1%), $451,906 in FY2015 (-64.2%), $1.26 million in FY2014 (+13.9%) and $1.11 million in FY2013.
- The fiscal Q3 2020 figure marks the lowest quarterly Non Operating Interest Expenses in data going back to fiscal Q1 2013.
- The best year-over-year quarter for Non Operating Interest Expenses over five years was fiscal Q1 2017 (growth of 57.6%); the worst was fiscal Q3 2020 (a decline of 60.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Anixa Biosciences | 101.33 Mn | 100.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2020 | 7,266.00 |
| Jul 31, 2019 | 18,364.00 |
| Oct 31, 2017 | 57,762.00 |
| Jul 31, 2017 | 71,667.00 |
| Apr 30, 2017 | 175,727.00 |
| Jan 31, 2017 | 195,299.00 |
| Oct 31, 2016 | 136,708.00 |
| Jul 31, 2016 | 132,357.00 |
| Apr 30, 2016 | 126,980.00 |
| Jan 31, 2016 | 123,901.00 |
| Oct 31, 2015 | 118,127.00 |
| Jul 31, 2015 | 115,981.00 |
| Apr 30, 2015 | 108,612.00 |
| Jan 31, 2015 | 109,186.00 |
| Oct 31, 2014 | 181,576.00 |
| Jul 31, 2014 | 280,913.00 |
| Apr 30, 2014 | 422,463.00 |
| Jan 31, 2014 | 378,665.00 |
| Apr 30, 2013 | 835,458.00 |
| Jan 31, 2013 | 22,195.00 |
API Access
Anixa Biosciences Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "ANIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=ANIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();